Published in OBGYN and Reproduction Week, April 18th, 2005
Study 1: Revised hormone replacement guidelines issued by European and French health authorities for prevention of postmenopausal osteoporosis are problematic for gynecologists, say two practitioners at the Hospital European Georges Pompidou, Paris.
A. Tamborini and J.-C. Ruiz wrote, "Hormone replacement therapy (HRT) [in] menopause has already proved to be effective in preventing bone loss and reducing the risk of fractures in postmenopausal women....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of OBGYN and Reproduction Week